Patents Assigned to NEUROSTIM TECHNOLOGIES LLC
  • Patent number: 11478638
    Abstract: A treatment for obstructive sleep apnea (“OSA”) of a user includes affixing a patch externally on a dermis of the user, the patch including a flexible substrate, an adhesive on a first side adapted to adhere to the dermis of the user, a processor directly coupled to the substrate, and electrodes directly coupled to the substrate. The treatment includes detecting an occurrence of OSA and activating the patch in response to the detecting, the activating including generating an electrical stimuli via the electrodes to activate the genioglossus muscle of the user.
    Type: Grant
    Filed: September 10, 2020
    Date of Patent: October 25, 2022
    Assignee: NEUROSTIM TECHNOLOGIES LLC
    Inventors: Hoo-min D. Toong, William C. Altmann
  • Patent number: 11458311
    Abstract: A topical nerve activation patch includes a flexible substrate, a dermis conforming bottom surface of the substrate comprising adhesive and adapted to contact a dermis of a user, a flexible top outer surface of the substrate, a plurality of electrodes positioned on the patch proximal to the bottom surface and located beneath the top outer surface and coupled to the flexible substrate, a power source, and electronic circuitry that generates an output voltage applied to the electrodes. The electronic circuitry includes a controller, a voltage monitoring circuit coupled to the controller, a current monitoring circuit coupled to the controller, a switch coupled to the controller and a two stage boosted voltage circuit coupled to the switch and the power source that is configured to increase a switch voltage level to approximately a half value of a final output voltage before increasing to the final output voltage.
    Type: Grant
    Filed: June 25, 2020
    Date of Patent: October 4, 2022
    Assignee: NEUROSTIM TECHNOLOGIES LLC
    Inventors: Alan E. Loh, Anthony Wei, Michael Bernard Druke
  • Patent number: 11305110
    Abstract: A treatment for obstructive sleep apnea (“OSA”) of a user includes affixing a patch externally on a dermis of the user, the patch including a flexible substrate, an adhesive on a first side adapted to adhere to the dermis of the user, a processor directly coupled to the substrate, and electrodes directly coupled to the substrate. The treatment includes detecting an occurrence of OSA and activating the patch in response to the detecting, the activating including generating an electrical stimuli via the electrodes to activate the genioglossus muscle of the user.
    Type: Grant
    Filed: March 19, 2020
    Date of Patent: April 19, 2022
    Assignee: NEUROSTIM TECHNOLOGIES LLC
    Inventors: Hoo-min D. Toong, William C. Altmann